Interestingly, we found that female patients were more sensitive to immunotherapy; monocytes have a potential role in affecting NSCLC immunotherapy; SEC14L3 and APCDD1L were the underlying targets affecting immunotherapy, as well as patients survival. The gene discussed is APCDD1L; the disease is non-small cell lung carcinoma.